updates

Tagrissohcp.com

Visit tagrissohcp.com

We collected all of metadata history records for Tagrissohcp.com. TAGRISSO Hcp has an elaborated description which rather positively influences the efficiency of search engines index and hence improves positions of the domain. The description and keywords of Tagrissohcp were last changed more than a year ago.

Tagrissohcp.com metadata updates

Title Description Keywords

May 04, 2021

Treatment for Resectable and Metastatic EGFRm NSCLC – TAGRISSO® (osimertinib)

Learn more about TAGRISSO® (osimertinib), a targeted therapy for the first-line treatment of metastatic EGFRm non-small cell lung cancer and for resec...

November 28, 2019

Treatment for Metastatic EGFRm NSCLC – TAGRISSO® (osimertinib)

Learn more about TAGRISSO® (osimertinib), a first-line treatment for metastatic EGFRm non-small cell lung cancer (NSCLC).

May 15, 2018

TAGRISSO® (osimertinib) | Treatment for Non-Small Cell Lung Cancer

Learn more about TAGRISSO® (osimertinib), a newly approved first-line treatment for your patients with metastatic non-small cell lung cancer (NSCLC).

January 05, 2017

TAGRISSO® (osimertinib) | Healthcare Professional Site

TAGRISSO is a treatment for EGFRT790M mutation-positive NSCLC that has progressed on or after EGFR tyrosine kinase inhibitor therapy.